Brand name and specialty drugs can be expensive. Almost all employment-based health insurance includes levels of copays on drugs and in some cases a deductible may be applicable as well. Concern has been raised about whether this cost-sharing may inhibit appropriate use of medications. A CDC brief based on 2013 survey data explores how adults deal with this issue. (CDC Brief) About 18% of drug costs in 2012 were paid out-of-pocket. According to the survey, 7.8% of adults over age 18 did not take a drug as prescribed to save money. This might include not filling the prescription or skipping doses. This tactic was less prevalent among Medicare eligible adults, only 4.4% of whom attempted to cut costs by not using the medication as recommended. Another 14.7% of all adults said they had asked their doctor for a lower-cost medicine, and here 17% of Medicare beneficiaries had done so. 1.6% purchased drugs from another country to limit their spending and 4.8% used an alternative therapy. As might be expected, the uninsured had higher rates of using these approaches to avoid spending. Medicaid patients, who often have no or very low copays, had lower rates, but still higher than the privately insured population. Poorer adults in general had the highest rates of not taking medication as prescribed and there was a clear association at all income levels, with higher income leading to more compliance with prescriptions. The survey findings indicate that for a substantial minority of the population, drug costs are a sufficient concern that they may be non-compliant with therapy. In many cases, this could lead to poorer health outcomes.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
December 2024 JOLTS Report
December 4, 2024
December 2024 JOLTS Report
When job numbers bounce around this much, it makes you wonder.
Commentary
Inflation Isn’t Going Away
December 3, 2024
Inflation Isn’t Going Away
Health care and health insurance prices are rising rapidly, contributing to ongoing inflation.